Figure 5.
HAS2 downregulation impairs CD44-related genes and self-renewal capacity. (a) U251MG cells stably transfected with shRNAs against HAS2 or control shRNA were grown in sphere-like conditions. HAS2-AS1, HAS2, VEGFA, and LOX mRNAs were quantified by real-time qPCR analysis and normalized to HPRT. (b) An ELDA assay was carried out in the HAS2 knockdown and control cells, and cells treated with the hyaluronan synthesis inhibitor 4-MU or DAPT. One representative experiment out of two is depicted.
